首页 | 本学科首页   官方微博 | 高级检索  
     

基于卷积运算构建循环淋巴细胞在肺癌CRT和SBRT中差异模型
引用本文:李书灵,沈怡超,陈奎妃,陈梦,杨海华. 基于卷积运算构建循环淋巴细胞在肺癌CRT和SBRT中差异模型[J]. 中华放射肿瘤学杂志, 2022, 31(11): 998-1003. DOI: 10.3760/cma.j.cn113030-20220106-00008
作者姓名:李书灵  沈怡超  陈奎妃  陈梦  杨海华
作者单位:绍兴文理学院医学院,绍兴 312000;浙江省台州医院放疗科,恩泽医学研究院放射肿瘤研究所,台州市放射肿瘤重点实验室,台州 317000
基金项目:浙江省公益基础项目(LGF21H160027); 浙江省肺癌诊治技术研究重大课题项目(JBZX‐201801); 国家自然科学基金(NSFC81874221)
摘    要:目的比较和验证常规分割放疗(CRT)和体部立体定向放疗(SBRT)在肺癌治疗中的差异。方法 基于卷积运算和有限元法构建模型,模拟放疗中传递到循环淋巴细胞(CL)的放射剂量。选取3例肺癌患者进行模型模拟,临床CRT(10例次)和SBRT(10例次)进行验证。比较两种方式下CL累积剂量峰值(PCDC)差异,分析不同治疗时间、计划靶区(PTV)对CL累积剂量的影响,并验证临床CL变化规律。结果 模拟集3例患者PTV分别为38、63、114 cm3,CRT的PCDC分别是1.26、1.79、2.54 Gy,SBRT的PCDC分别是0.84、1.22、1.55 Gy;同样PTV中,SBRT分别减少了0.42、0.57、0.99 Gy。验证集中,CRT和SBRT的CL变化值分别是(1.10±0.64)×109/L和(0.42±0.48)×109/L,差异有统计学意义(P=0.015);CRT和SBRT组PCDC分别是3.56(2.79,3.82)Gy和1.24(0.697,1.73)Gy,差异有统计学意义(P<0.001);CL变化值与PCDC呈正显著相关(r=0.455,P<0.05)。结论 SBRT比CRT的PCDC、CL变化值更小;且随着PTV的增大,两者的PCDC差异可能越明显;CRT和越大的PTV可能对机体免疫功能产生越大的影响。

关 键 词:体部立体定向放射疗法  常规分割放射疗法    非小细胞肺  循环淋巴细胞  免疫抑制  
收稿时间:2022-01-06

Modelling the difference of circulating lymphocytes between conventional fractionation radiotherapy and stereotactic body radiation therapy for lung cancer based on convolution operation
Li Shuling,Shen Yichao,Chen Kuifei,Chen Meng,Yang Haihua. Modelling the difference of circulating lymphocytes between conventional fractionation radiotherapy and stereotactic body radiation therapy for lung cancer based on convolution operation[J]. Chinese Journal of Radiation Oncology, 2022, 31(11): 998-1003. DOI: 10.3760/cma.j.cn113030-20220106-00008
Authors:Li Shuling  Shen Yichao  Chen Kuifei  Chen Meng  Yang Haihua
Affiliation:School of Medicine, Shaoxing University,Shaoxing 312000, China;Department of Radiation Oncology, Taizhou Hospital, Institute of Radiation Oncology, Enze Medical Research Institute, Taizhou Key Laboratory of Radiation Oncology,Taizhou 317000, China
Abstract:Objective To evaluate the difference between conventional fractionation radiotherapy (CRT) and stereotactic body radiation therapy (SBRT) in lung cancer. Methods A model was constructed based on convolution operation and finite element method, simulating the dose delivered to circulating lymphocytes (CL) in radiotherapy. The model was trained on a training group (n=3) and validated in an independent validation group between SBRT (n=10) and CRT (n=10). The peak cumulative dose of circulating lymphocyte (PCDC) was compared between the two schemes, and the effect of different PTV volumes and treatment time on the cumulative dose was also analyzed. The correlation between PCDC and CL change value was discussed. Results In the training group, PCDC with CRT to CL were 1.26 Gy,1.79 Gy, 2.54 Gy in PTV of 38 cm3, 63 cm3 and 114 cm3, and PCDC with SBRT to CL were 0.84 Gy, 1.22 Gy, 1.55 Gy in PTV of 38 cm3, 63 cm3, 114 cm3, respectively. PCDC gap of SBRT to CL was decreased by 0.42 Gy, 0.57 Gy, 0.99 Gy, respectively. In the validation group, the lymphocyte change value in SBRT and CRT were (1.10±0.64)×109/L and (0.42±0.48)×109/L, and there was significant difference (P=0.015). PCDC in SBRT and CRT were 3.56 (2.79, 3.82) Gy and 1.24 (0.697, 1.73) Gy, and there was significant difference (P<0.001). There was a positive correlation between lymphocyte change value and PCDC (r=0.455, P<0.05). Conclusions SBRT, compared to CRT, will lead to lower PCDC and CL lymphocyte change value, which may cause a greater impact on the difference of PCDC along with the enlargement of PTV. CRT and large PTV volume may cause more significant effect upon the body immune function.
Keywords:Stereotactic body radiation therapy  Conventional fractionation radiotherapy  Carcinoma  non‐small cell lung  Circulating lymphocytes  Immunosuppression  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号